WealthQuest Citadel 7 Diamond (NY) review

Not really, and not for the reason a shopper skimming the rate sheet would expect. It's not a bad *contract* — the carrier is solid (A.M. Best A), the death benefit is uncomplicated, and there's no rider fee dragging on returns. What makes it a weak choice is that the advertised rate is only true for 12 months, and the product it should be compared against — American National's own Palladium MYG 7 (NY) — offers a flat, fully guaranteed rate for the whole 7-year term at a level that outpaces what Citadel 7 Diamond is likely to average once the enhancement burns off.

The honest reason someone buys this is the year-one number. If a shopper is comparing "current rate" columns across products without reading the crediting mechanics, 5.10%–5.20% looks like a strong one-year fixed rate from an A-rated NY carrier, and for that single year, it is. Someone parking money for 12-24 months, planning to reassess or move funds once the enhancement expires, could reasonably use this product for that narrow window — especially since the free-withdrawal and waiver provisions give some flexibility if plans change.

This fits a narrow buyer: someone in New York (this is the NY-only filing, not sold anywhere else) who wants the best short-term guaranteed rate they can find, understands the rate steps down after year one, and either plans to use the free-withdrawal allowance to reposition money or genuinely doesn't mind that years two through seven pay meaningfully less. It is a poor fit for someone who reads "5.10%" and assumes that's what the money earns for seven years — that reader should look at Palladium MYG 7 (NY) instead.

Strip away the marketing and this is a fixed-rate annuity where the "current rate" quoted by Wink and printed in sales materials is a blended figure: a declared base rate plus a temporary interest rate enhancement. American National is explicit that this is an *interest rate enhancement*, not a premium bonus — nothing extra is added to the account value itself. It's purely a rate boost applied to interest crediting for the first 12 months following receipt of each premium. Once that boost expires, the account reverts to the base declared rate, and that base rate is only locked for a total of two years from the date the premium was received. After that, American National re-declares the rate annually, and there is no guarantee it stays anywhere near 3.10%/3.20% — the only floor is the contract's minimum guaranteed interest rate (1%-3%, set at issue for the life of the contract).

Here's the year-by-year mechanics as best they can be reconstructed from the Wink profile and consumer brochure: a premium under $100,000 earns 5.10% in year one (3.10% declared base plus a 2.00% first-year interest enhancement). A premium of $100,000 or more earns 5.20% in year one (3.10% base, plus a 0.10%/year large-premium add-on that brings the base to 3.20%, plus the same 2.00% enhancement). From year two onward, the enhancement is gone and the contract credits the base rate — roughly 3.10% or 3.20% — for the remainder of the two-year initial guarantee window, then that base rate is re-declared annually for years three through seven, at whatever rate American National sets at that time (no worse than the guaranteed minimum).

If that base rate simply held flat for the full term — which is an assumption, not a promise — the blended average over seven years would land around 3.4%-3.5%, not 5.10%-5.20%. Compare that to Palladium MYG 7 (NY), the carrier's flat-rate 7-year sibling, which (per the same Wink snapshot era) guarantees 3.95% for all seven years, no teaser, no re-declaration risk. That's a materially better outcome for a buyer who actually wants their money locked at a known rate for the full term, and it comes with less structural uncertainty.

The death benefit is the product's cleanest feature: full account value, paid on the owner's death, with no surrender charges deducted regardless of where the contract sits in its surrender schedule. Combined with the disability and confinement surrender-charge waivers (each usable up to a $250,000 lifetime aggregate across all contracts the owner holds with this carrier), there's real flexibility built in for life events that would otherwise trap money behind a penalty. Those features don't offset the rate structure, but they matter for someone weighing legacy planning or worried about needing early access due to illness.

The 7% starting surrender charge sits at the higher end for a 7-year product and holds flat through year three before stepping down — 7%, 7%, 7%, 6%, 5%, 4%, 2%. The standard 10% annual free withdrawal (minimum $250 per partial withdrawal) gives some access without penalty, and systematic withdrawal options — including interest-only withdrawals — add flexibility for someone who wants to draw off earnings rather than touch principal. The disability and confinement waivers extend that further for genuine hardship situations. None of this changes the core issue: this is a 7-year commitment being marketed on a rate that only applies for one of those seven years.

There's nothing to dislike on the fee side — no M&E charge, no product fee, no administration charge, no annual contract fee, and no income rider fee since there's no income rider. The real cost here isn't a line-item fee; it's the rate structure itself. A buyer who commits for the full surrender period expecting a 5%+ rate to keep compounding is going to be surprised in year two, and the fact that the base rate isn't even locked past year two adds a layer of re-declaration risk that a flat-rate MYGA sibling like Palladium MYG 7 (NY) simply doesn't have.

Legal Entity: American National Life Insurance Company of New York

Parent: American National Group

A.M. Best Rating: A